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Abstract. The article discusses the treatment and prevention of feed toxicosis of pigs. A composition based 
on montmorillonite-containing minerals is considered as a promising enterosorbent in combination with the 
drug vievitin in the treatment of pig dysentery. Studies have shown that the complex use of vievitin with a 
sorbent by giving individually in 100 ml of drinking water at doses of 5.6 (second group) and 11.1 (third 
group) mg/kg body weight for vievitin and 400 mg/kg body weight bodies for the sorbent provided a high 
therapeutic effect in the treatment of piglets suffering from dysentery. Recovery, respectively, was 90.8 and 
93.8%. 
1 Introduction 
Intestinal disorders in the family of non-ruminant 
artiodactyls of farm animals have different etiologies, are 
widespread, and significantly affect the productivity and 
health of the entire livestock population. Moreover, large 
and medium-sized pig farms are serious sources of 
microbiological pollution of the environment, especially 
when outbreaks of diseases of the gastrointestinal tract 
occur in livestock farms. The cause of this problem can be 
not only dysentery of various pathogenesis, but also 
including feed toxicosis. [1] 
A characteristic feature of feed toxicosis that 
distinguishes them from infectious diseases is the absence 
of contagiousness, while etiological factors may include 
the presence in the feed of microorganisms, toxic waste 
products of fungi - mycotoxins, heavy metal ions, 
radionuclides, half-life products of organic phenols and 
other substances. [2] The severity and clinical 
manifestation of feed toxicosis depends on the number of 
non-benign diet ingredients, the duration of their use and 
the immuno-biological state of the animal organism. 
For the treatment and correction of gastrointestinal 
disorders developing in acute diarrheal infectious diseases, 
eubiotics, enzyme preparations, antispasmodics and a 
number of other groups of drugs are used in clinical 
practice, among which in recent years they have given 
increasing importance to enterosorbents. [3] 
Enterosorption is included in the group of efferent therapy 
(lat. Efferens - display), i.e. therapeutic measures, the 
purpose of which is to stop the action of toxins of various 
origins and their elimination from the body. 
Enterosorption in intestinal infectious diseases is a 
pathogenetically substantiated method of therapy. [4]  
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In recent years, there have been reports of the use of 
montmorillonite-containing clays for serious intoxication 
of the body, both humans and animals. No worse than 
modern antibiotics, they cope with pathogenic bacteria. 
But, unlike medicines, clay itself remains chemically inert, 
and, therefore, absolutely harmless to the body, clay 
inactivates only harmful microbes and toxins, renewing 
cells, and promotes the formation of immunity. The 
therapeutic effect of clay natural materials such as 
montmorillonite (smectite) is explained by their sorption-
adhesive and ion-selective properties, as well as by the 
saturation of various mineral elements, some of which are 
in a bioavailable form. Once inside the body, natural 
sorbents, by normalizing the content of micro and macro 
elements, are able to stimulate the processes of auto-
regulation of the metabolism of substances. It has been 
established that when they are used, intestinal function is 
normalized, reproductive ability and resistance of the body 
are increased, live weight gain is increased, and qualitative 
indicators of production: meat, milk, eggs, are improved. 
With the help of natural sorbents based on 
montmorillonite, gastrointestinal diseases can be 
prevented. [5,6] The authors proved that bentonite clays 
are effective in the prevention and treatment of diarrhea in 
piglets, especially in the post-weaning period. [7]  
Thus, the aim of this work was to improve the method 
for the treatment and prevention of intestinal disorders of 
pigs by oral administration of a composite preparation 
consisting of: vievitin and enterosorbent. 
2 Experimental 
Materials and research methods. The therapeutic efficacy 
of the oral administration of a composite preparation 
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(vievitin with enterosorbent) was determined in scientific 
and economic experiments on 3-4 months of age of pigs 
with dysentery, of which 5 groups were formed. 
The diagnosis of dysentery was established on the basis 
of epizootological data, clinical signs of the disease, 
pathological changes and the results of bacteriological 
studies. Sick piglets were kept in sanitary machines. 
During therapeutic and prophylactic treatments of pigs 
with a composite preparation (Patent for invention No. 
2589678), the machines containing patients and pigs 
suspected of being infected with dysentery were regularly 
thoroughly cleaned, and the animal excrement areas were 
disinfected with stalosan - Р¤ based on 50.0 g/m2. At the 
same time, the passageways and corridors of the manure 
collection channels of the dysfunctional premises were 
disinfected with a 4% hot (70В°C) sodium hydroxide 
solution. 
Vievitinum is an antibacterial drug in the form of a 
powder for oral use, intended for the treatment of pigs 
suffering from bacterial and mycoplasma infectious 
diseases. In 1g of vievitin, 450mg of thiamulin 
hydrofumarate is contained as the active substance, and 
350mg as glucose auxiliary components and 200mg as 
glucose. The developer of this drug for veterinary use is 
GNU named after Y.R. Kovalenko, Moscow. The drug 
was registered by the Federal Service for Veterinary and 
Phytosanitary Surveillance on December 30, 2010. 
Registration certificate of the medicinal product for 
veterinary use No. 000126. Registration certificate 
number: 77-3-3.0-0105 No. PVR-3-3.0/02656. 
In preliminary studies, data were obtained on the 
determination of the sensitivity of Brachyspira 
hyodysenteriae to vievitin. In this case, the minimum 
bacteriostatic concentration of the drug (in terms of the 
active substance) ranged from 0.06-0.38 Ојg/ml, and the 
bactericidal concentration in the range of 1.9-7.5 Ојg/ml. 
The enterosorbent used in the experiment is an 
enrichment product for clay raw materials from deposits in 
the Belgorod Region (Patent for the invention No. 
2471549). 
The composite preparation was prepared in a 
laboratory ball mill RTA-1 in the following proportions: 
- for the first group of animals: 5.6 g of vievitin and 
400 g of sorbent (1 g of the drug contained 14 mg of 
vievitin and 986 mg of sorbent); 
- for the second group of animals: 11.1 g of vievitin and 
400 g of sorbent (1 g of the drug contained 27 mg of 
vievitin and 973 mg of sorbent); 
- for the third group of animals: 22.0 g of vievitin and 
409 g of sorbent (52 g of vievitin and 948 mg of sorbent 
were contained in 1 g of the drug). 
Animals of the first group (n = 63) received a 
composite preparation at a dose of 5.6 mg/kg of body 
weight of vievitin (2.5 mg/kg of active substance) and 400 
mg/kg of body weight of the sorbent, the second (n = 65) - 
11, 1 mg/kg body weight of vievitin (5 mg/kg of active 
substance) and 400 mg/kg of body weight of the sorbent, 
the third (n = 64) - 22.2 mg/kg of body weight of 
vievitin (10 mg/kg of active substance) and 400 mg/kg of 
body weight of the sorbent. 
 Piglets of the fourth and fifth groups served as control. 
The fourth group (n = 58) was orally administered with 
vievitin at a dose of 11.1 mg/kg, and the fifth (n = 60) was 
administered sorbent at a dose of 400 mg/kg of body 
weight (Table 1). 
Each dose of the drug was dissolved in 100 ml of 
drinking water and was individually drunk from a rubber 
bottle once a day for three days. 
3 Results and discussions 
The sorption efficiency of enterosorbent prepared on 
the basis of montmorillonite-containing clay (MCC) and 
the cell wall of Pichia Pastoris was studied, and a 
comparison was made with the American analogue of 
Mikosorb. In Fig. 1. The comparative characteristic of the 
sorption ability, determined by the absorption of the dye, 
is presented. During the experiment, it was proved that the 
entrosorbent based on montmorillonite has a more 
pronounced sorption ability in relation to the Mikosorb 
analog by 59.1%. 
Clinical studies of enetrosorbent in combination with 
viveetin showed that on the second day of treatment, 
animals of groups II and III were characterized by an 
improvement in the clinical condition, instead of bloody 
diarrhea, liquid or watery bowel movements were 
observed, and single brahispir was found in smears from 
feces. Among the main number of piglets of the first group, 
clinical signs of dysentery were noted. 
The bulk of the experimental animals of the second and 
third groups recovered after two or three days of treatment 
(the appetite recovered, feces were formed, there were no 
brachyspirs in smears from rectal samples), and only a few 
individuals on the next day after the end of the course of 
treatment. Mortality among piglets of the second and third 
groups was observed on the first day of the experiment. In 
addition, two heads were forcedly killed in the second and 
third groups. 
 
Table 1. Scheme of experience in determining the therapeutic efficacy of a composite preparation (vievitin in combination with a 
sorbent) in peg dysentery. 
Group 
Composite preparation, dose 
mg/kg body weight Application method Multiplicity of application 
Vievitin Enterosorbent 
I 5,6 400 
Individually with drinking water Once a day for three days II 11,1 400 
III 22,2 400 
Conrol 
IV 11,1 - Individually with drinking water Once a day for three days 
V - 400 Individually with drinking water Once a day for three days 
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Fig. 1. Comparative characteristic of the sorption capacity for 
dye absorption 
In the first group, animals were cured only three days 
after the start of treatment, a small proportion of pigs 
recovered after the end of treatment, and 20.6% did not 
recover. The waste of animals in this group was large, 
since 7 animals fell and 6 were forcedly killed (Table 2). 
Cured animals quickly returned to normal (food intake 
was restored, feces acquired a dense consistency, and 
brahispira were not found in rectal samples). Relapse of 
the disease in all three groups during the 3-week 
observation period was not recorded. 
In the control groups, where the fourth group used 
vievitin at a dose of 11.1 mg/kg, and the fifth used a 
sorbent at a dose of 400 mg/kg, on the second day of 
treatment the clinical picture of the disease did not 
disappear, but the general condition of the animals was 
fifth the group worsened (appetite is reduced or absent, 
sunken sides, dull hair and disheveled, diarrhea with 
impurities of blood and mucus, voice squeaky hoarse). 
There was also a large departure of animals (in the fourth 
group, 5 animals fell and 3 were killed, and in the fifth - 6 
animals and 3 were killed). 
On the third day of treatment in the fourth group, the 
death of the pigs stopped, but 4 piglets were rejected. In 
the fifth group, 3 gilts fell and 4 were forcedly killed. In 
order to prevent further mortality, the remaining animals 
of the fifth group were treated with injections of tiamulin 
hydrofumarate. The antibiotic was administered 
intramuscularly once a day for three days at a dose of 15 
mg/ kg. 
After the course of treatment, the pigs of the fourth 
group are completely healthy. 
Given the fact that the therapeutic efficacy of using 
vievitin with sorbent in appropriate doses of 11.1 mg/kg 
body weight of vievitin (5 mg/kg of active substance) and 
400 mg/kg of body weight of the sorbent was 90.8%, then 
this dose used as a preventive when giving food. 
Also, the decision to use the studied complex with food 
was based on the fact that piglets suspected of dysentery 
infection, as a rule, do not suffer from a lack of appetite, 
and the appointment of these funds with food is less time-
consuming and technologically advanced than the 
individual giving of therapeutic drugs with drinking water. 
Therefore, the composite preparation was dissolved in 
water, mixed with food and fed in a group way to 60 piglets 
in contact with pigs suffering from dysentery once a day 
for two days. During the 3-week follow-up, these pigs 
were clinically healthy, and no brahispira were found in 
smears from feces. 
Studies have shown that the combined use of vievitin 
with a sorbent by giving individually 100 ml of drinking 
water at doses of 5.6 (second group) and 22.2 (third group) 
mg/kg body weight for vievitin and 400 mg/kg wt - body 
for the sorbent provided a high therapeutic effect in the 
treatment of piglets suffering from dysentery. Recovery, 
respectively, was 90.8 and 93.8%. 
The oral form of using vievitin with enterosorbent, 
unlike the injection form of thiamulin hydrofumarate, does 
not lead to the development of prophylactic reactions, has 
a more sparing effect on the immune system, is safer and 
more convenient in practice, which expands the scope of 
the drug. The combined use of vievitin in combination 
with an enriched montmorillonite-containing sorbent 
additionally provides efferent therapy, increases the 
effectiveness of treatment and prevention of dysentery, 
promotes the rapid recovery of sick animals, and reduces 
the expense and side effect of vivitin on the body. 
Giving sorbent selectivity by immobilizing specific 
vievitin ligands on its surface is a new direction in sorption 
therapy. The weakly immobilized vievitin ligands formed 
upon enterosorption are quite easily desorbed from the 
surface of the sorbent. In this case, the sorbent acts as a 
carrier for the delivery, dosed release and prolongation of 
the action of bioactive ligands, and also additionally 
performs the function of protecting immobilized ligands 
from inactivating factors of the external (during long-term 
storage) and internal (e.g., gastric juice) environment. In 
addition, in this embodiment, the sorbent-immobilized 
vievitin system has a certain buffer capacity, that is, it 
works as a depot warehouse, from which the body selects 
the antibiotic for its needs in necessary quantities as 
necessary, and the risks of overdoses are reduced.
 
Table 2. Therapeutic efficacy of a composite preparation (vievitin in combination with sorbent) in pig dysentery. 
Group Number of 
heads 
Died Forced killed Recovered 
Heads % Heads % Heads % 
I 63 7 11,1 6 9,5 50 79,4 
II 65 4 6,1 2 3,1 59 90,8 
III 64 2 3,1 2 3,1 60 93,8 
Control 
IV 58 5 8,6 7 12,1 46 79,3 
V 60 9 15,0 7 11,7 * * 
Note: * - treatment is discontinued due to lack of therapeutic effect. 
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Summarizing the above materials, it can be noted that 
enterosorption in intestinal infectious diseases is a 
pathogenetically substantiated method of therapy. An 
approach based on imparting specific properties to the 
sorbent by immobilizing bioactive vievitin ligands on its 
surface is promising. [8] It allows you to reduce or even 
eliminate the negative impact on the body of the animal 
drug substance vievitin. The use of montmorillonite-
containing clays, which ensure the effectiveness of 
efferent methods of therapy, in combination with 
promising antibacterial drugs, provides a wide opportunity 
for the development of preventive and therapeutic 
complex preparations with increased therapeutic activity. 
[9] 
These drugs are usually more cost-effective than 
antibiotics, due to the fact that their main ingredient is, as 
a rule, environmentally friendly enterosorbents obtained 
on the basis of natural domestic raw materials and having 
increased efficiency of sorption of exo- and endotoxins of 
enteropathogenic microorganisms, products of decay yes 
the contents of the intestines and other pollutants. The 
duration of their use in the treatment and prevention of 
gastroenteritis of infectious etiology is much shorter than 
that of antibacterial drugs, because many antibiotics are 
designed for a long course of treatment. 
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